Business · 13/12/2021Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Six Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of six abbreviated new drug applications (ANDAs) from multiple pharmaceutical companies, following written notifications that the approved drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →